GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Cyclically Adjusted PB Ratio

Taiko Pharmaceutical Co (TSE:4574) Cyclically Adjusted PB Ratio : 1.02 (As of Jun. 06, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-06-06), Taiko Pharmaceutical Co's current share price is 円375.00. Taiko Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円368.57. Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.02.

The historical rank and industry rank for Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4574' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.73   Med: 2.06   Max: 8.68
Current: 1

During the past years, Taiko Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 8.68. The lowest was 0.73. And the median was 2.06.

TSE:4574's Cyclically Adjusted PB Ratio is ranked better than
72.68% of 732 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs TSE:4574: 1.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Taiko Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was 円148.017. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円368.57 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Taiko Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Taiko Pharmaceutical Co Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.02 4.78 2.27 1.05

Taiko Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.02 0.92 0.94 0.82 1.05

Competitive Comparison of Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Taiko Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=375.00/368.57
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiko Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Taiko Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=148.017/107.2000*107.2000
=148.017

Current CPI (Mar. 2024) = 107.2000.

Taiko Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 281.877 98.000 308.339
201409 284.470 98.500 309.596
201412 313.122 97.900 342.867
201503 325.307 97.900 356.210
201506 318.945 98.400 347.469
201509 320.631 98.500 348.951
201512 336.051 98.100 367.224
201603 336.175 97.900 368.110
201606 328.447 98.100 358.915
201609 364.431 98.000 398.643
201612 388.784 98.400 423.553
201703 363.172 98.100 396.861
201706 358.377 98.500 390.031
201709 362.687 98.800 393.523
201712 384.543 99.400 414.718
201803 384.421 99.200 415.423
201806 376.277 99.200 406.622
201809 387.137 99.900 415.426
201812 403.697 99.700 434.065
201903 406.335 99.700 436.902
201906 397.937 99.800 427.443
201909 407.381 100.100 436.276
201912 440.220 100.500 469.568
202003 451.271 100.300 482.316
202006 481.328 99.900 516.500
202009 511.067 99.900 548.412
202012 525.929 99.300 567.770
202103 506.402 99.900 543.406
202106 459.918 99.500 495.510
202109 469.976 100.100 503.311
202112 293.819 100.100 314.659
202203 254.995 101.100 270.380
202206 233.610 101.800 246.002
202209 225.281 103.100 234.240
202212 184.575 104.100 190.071
202303 179.848 104.400 184.672
202306 192.467 105.200 196.126
202309 197.288 106.200 199.146
202312 134.895 106.800 135.400
202403 148.017 107.200 148.017

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Taiko Pharmaceutical Co  (TSE:4574) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Taiko Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiko Pharmaceutical Co (TSE:4574) Business Description

Traded in Other Exchanges
N/A
Address
No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032
Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co (TSE:4574) Headlines

No Headlines